- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Amyloidosis Beta2M
Total 970 results
-
University of EdinburghCompleted
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique
-
Shahid Beheshti University of Medical SciencesCompleted
-
Ionis Pharmaceuticals, Inc.Approved for marketingAmyloidosis, Hereditary
-
Federico II UniversityEnrolling by invitation
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
University of PennsylvaniaAstraZeneca; Ionis Pharmaceuticals, Inc.Active, not recruitingHereditary Amyloidosis, Transthyretin-RelatedUnited States
-
Chulalongkorn UniversityRatchadapiseksompotch FundUnknownLichen AmyloidosisThailand
-
University Hospital, LimogesMinistry of Health, FranceCompletedPrimary Systemic Amyloidosis (AL)France
-
Timothy PoteruchaPfizer; American Heart Association; Eidos Therapeutics, a BridgeBio companyRecruiting
-
Assiut UniversityNot yet recruiting
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia
-
Saving Lives MattersRecruiting
-
Turkish Society of CardiologyRecruiting
-
Medical College of WisconsinTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalTerminatedCardiac AmyloidosisUnited States
-
University of MessinaCampisi MariapaolaUnknownCardiac AmyloidosisItaly
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Seoul National University HospitalCW pharmaceutical companyUnknownCardiac AmyloidosisKorea, Republic of
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
IRCCS Policlinico S. MatteoCompleted
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
PfizerCompletedTransthyretin-associated Amyloidosis With PolyneuropathyUnited States, France, Germany, Italy
-
Oncology Institute of Southern SwitzerlandUniversity of Kiel; Ente Ospedaliero Cantonale, BellinzonaCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, Canada, United Kingdom
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
Mayo ClinicRecruitingHealthy Adults | Amyloidosis CardiacUnited States
-
Alnylam PharmaceuticalsCompletedTransthyretin Mediated Amyloidosis (ATTR)United Kingdom, France, Portugal, Sweden
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
Unity Health TorontoPfizerNot yet recruiting
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
Istanbul UniversityCompleted
-
Zhejiang UniversityRecruitingTransthyroxin Amyloidosis CardiomyopathyChina
-
Alnylam PharmaceuticalsCompletedTransthyretin-mediated Amyloidosis (ATTR Amyloidosis)United Kingdom
-
Alnylam PharmaceuticalsRecruitingHereditary Amyloidosis, Transthyretin-Related | Asymptomatic Carrier StateFrance
-
Oregon Health and Science UniversityAttralus, Inc.RecruitingAmyloidosis | Transthyretin AmyloidosisUnited States
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruiting
-
Wuhan Union Hospital, ChinaRecruiting
-
Attralus, Inc.CompletedAmyloidosis; SystemicUnited States
-
Prothena Biosciences LimitedTerminatedAmyloidogenic Transthyretin (ATTR) AmyloidosisUnited States, Spain, Sweden, Portugal
-
Fábio FernandesPfizerUnknown
-
University of Texas Southwestern Medical CenterRecruitingTransthyretin Cardiac AmyloidosisUnited States